for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-‍Novartis' Rydapt Approved Following Priority Review By Health Canada​

Dec 5 (Reuters) - Novartis Ag:

* NOVARTIS PHARMACEUTICALS CANADA - RYDAPT (MIDOSTAURIN) HAS BEEN APPROVED FOLLOWING A PRIORITY REVIEW BY HEALTH CANADA Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up